Anti-CD44 antibody [MEM-263]
- BOND RX™ Validated
- KO Validated
- Lab Essentials
- What is this?
Be the first to review this product! Submit a review
|
(12 Publications)
Mouse Monoclonal CD44 antibody. Suitable for IHC-P, Flow Cyt, WB and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Cell preparation containing CD44 protein.
View Alternative Names
CD44, LHR, MDU2, MDU3, MIC4, CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, ECMR-III, PGP-1, PGP-I
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [MEM-263] (AB9524)
IHC image of CD44 staining in Human Skin Melanoma formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab9524, 0.5 μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD44 antibody [MEM-263] (AB9524)
Human peripheral blood lymphocytes stained with ab9524 (red line). Human whole blood was processed using a modified protocol based on Chow et al, 2005 (PMID : 16080188). In brief, human whole blood was fixed in 4% formaldehyde (methanol-free) for 10 min at 22°C. Red blood cells were then lyzed by the addition of Triton X-100 (final concentration - 0.1%) for 15 min at 37°C. For experimentation, cells were treated with 50% methanol (-20°C) for 15 min at 4°C. Cells were then incubated with the antibody (ab9524, 0.1μg/1x106 cells) for 30 min at 4°C. The secondary antibody used was Alexa Fluor® 488 goat anti-mouse IgG (H&L) (ab150113) at 1/2000 dilution for 30 min at 4°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >30,000 total events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. Gating strategy - peripheral blood lymphocytes.
- WB
Lab
Western blot - Anti-CD44 antibody [MEM-263] (AB9524)
Lanes 1 - 4 : Merged signal (red and green). Green - ab9524 observed at 80 kDa. Red - loading control, ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) observed at 55kDa.
ab9524 was shown to react with CD44 in wild-type HeLa cells in western blot. Loss of signal was observed when CD44 knockout sample was used. Wild-type and CD44 knockout HeLa cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab9524 and ab52866 (Rabbit anti-alpha Tubulin antibody [EP1332Y]) overnight at 4°C at 2 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CD44 antibody [MEM-263] (ab9524) at 2 µg/mL
Lane 1:
Wild-type HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
CD44 knockout HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CD44 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cd44-knockout-hela-cell-line-ab262515'>ab262515</a>)
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
LNCaP (Human prostate cancer cell line) whole cell lysate at 20 µg
Predicted band size: 81 kDa
Observed band size: 80 kDa
false
- WB
Unknown
Western blot - Anti-CD44 antibody [MEM-263] (AB9524)
Western blotting of HPB-ALL cell lysate (non-reduced sample) stained by ab9524. Western blotting of HPB-ALL cell lysate (non-reduced sample) stained by ab9524.
All lanes:
Western blot - Anti-CD44 antibody [MEM-263] (ab9524)
Predicted band size: 81 kDa
false
- WB
Supplier Data
Western blot - Anti-CD44 antibody [MEM-263] (AB9524)
All lanes:
Western blot - Anti-CD44 antibody [MEM-263] (ab9524) at 2 µg/mL
Lane 1:
MOLT-4 cells (human T lymphoblast; acute lymphoblastic leukemia)
Lane 2:
HeLa cells (human epithelial cell line from cervix adenocarcinoma)
Predicted band size: 81 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 15:1479458 PubMed39872532
2025
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 4:102177 PubMed37086411
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35628262
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35563359
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 20:150 PubMed35305656
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 53:291-299 PubMed33603128
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oral diseases 27:1383-1393 PubMed32593227
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biology of reproduction 98:752-764 PubMed29546322
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 5:9447 PubMed25819560
2015
Applications
IHC-P
Species
Unspecified reactive species
Molecular cancer therapeutics 11:2384-93 PubMed22933702
2012
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com